Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jiangfang Feng
Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments
Related publications
Characteristics of Dasatinib- And Imatinib-Resistant Chronic Myelogenous Leukemia Cells
Clinical Cancer Research
Cancer Research
Oncology
Suboptimal Responses to Imatinib in Chronic Myelogenous Leukemia
Clinical Journal of Oncology Nursing
Oncology
Activin a Induction of Erythroid Differentiation Sensitizes K562 Chronic Myeloid Leukemia Cells to a Subtoxic Concentration of Imatinib
American Journal of Physiology - Cell Physiology
Physiology
Cell Biology
ITR‑284 Modulates Cell Differentiation in Human Chronic Myelogenous Leukemia K562 Cells
Oncology Reports
Medicine
Cancer Research
Oncology
An Analysis of Strategic Treatment Interruptions During Imatinib Treatment of Chronic Myelogenous Leukemia With Imatinib-Resistant Mutations
Mathematical Biosciences
Statistics
Genetics
Probability
Molecular Biology
Biochemistry
Applied Mathematics
Microbiology
Simulation
Immunology
Biological Sciences
Medicine
Agricultural
Modeling
Cytotoxic Effects of Some Flavonoids and Imatinib on the K562 Chronic Myeloid Leukemia Cell Line: Data Analysis Using the Combination Index Method
Balkan Medical Journal
Medicine
Antileukemic Activity of Lysophosphatidic Acid Acyltransferase- Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib
Clinical Cancer Research
Cancer Research
Oncology
Comparison Between Effects of Free and Niosomal Formulations of Artemisia Annua L. (Asteraceae) on Chronic Myelogenous Leukemia (K562) Cell Line
International Journal of Pharmacology
Pharmacology
Synergistic Effect of HMGB1 Knockdown and Cordycepin in the K562 Human Chronic Myeloid Leukemia Cell Line
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine